View in EDS HTML Full Text PDF Full Text

The clinicopathological characteristics, oncologic outcomes and costs of "HER2-low" early breast cancer compared to HER2-zero and HER2-positive: a single-centre retrospective analysis.

Saved in:
Bibliographic Details
Title: The clinicopathological characteristics, oncologic outcomes and costs of "HER2-low" early breast cancer compared to HER2-zero and HER2-positive: a single-centre retrospective analysis.
Authors: Rodrigues PR; Department of Medical Oncology, Portuguese Oncology Institute, Porto, Portugal., Lopes-Conceição L; Epidemiology, Outcomes, Economics and Management in Oncology Group - Research Center (CI-IPOP), Porto Comprehensive Cancer Center (Porto.CCC), RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto, Porto, Portugal., Sousa V; Epidemiology, Outcomes, Economics and Management in Oncology Group - Research Center (CI-IPOP), Porto Comprehensive Cancer Center (Porto.CCC), RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto, Porto, Portugal.; Oncology Adult Day Hospital Unit, Portuguese Oncology Institute, Porto, Portugal., Coutada A; Department of Anatomical Pathology, Portuguese Oncology Institute, Porto, Portugal., Bento MJ; Epidemiology, Outcomes, Economics and Management in Oncology Group - Research Center (CI-IPOP), Porto Comprehensive Cancer Center (Porto.CCC), RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto, Porto, Portugal.; Department of Population Studies, Abel Salazar Institute of Biomedical Sciences, University of Porto, Porto, Portugal., Coimbra N; Department of Anatomical Pathology, Portuguese Oncology Institute, Porto, Portugal., Leal C; Department of Anatomical Pathology, Portuguese Oncology Institute, Porto, Portugal., Pereira D; Department of Medical Oncology, Portuguese Oncology Institute, Porto, Portugal., Magalhães Ferreira A; Department of Medical Oncology, Portuguese Oncology Institute, Porto, Portugal.; Abel Salazar Institute of Biomedical Sciences, University of Porto, Porto, Portugal.
Source: Frontiers in oncology [Front Oncol] 2025 Sep 17; Vol. 15, pp. 1579602. Date of Electronic Publication: 2025 Sep 17 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41040514
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The clinicopathological characteristics, oncologic outcomes and costs of "HER2-low" early breast cancer compared to HER2-zero and HER2-positive: a single-centre retrospective analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rodrigues+PR%22">Rodrigues PR</searchLink>; Department of Medical Oncology, Portuguese Oncology Institute, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Lopes-Conceição+L%22">Lopes-Conceição L</searchLink>; Epidemiology, Outcomes, Economics and Management in Oncology Group - Research Center (CI-IPOP), Porto Comprehensive Cancer Center (Porto.CCC), RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Sousa+V%22">Sousa V</searchLink>; Epidemiology, Outcomes, Economics and Management in Oncology Group - Research Center (CI-IPOP), Porto Comprehensive Cancer Center (Porto.CCC), RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto, Porto, Portugal.; Oncology Adult Day Hospital Unit, Portuguese Oncology Institute, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Coutada+A%22">Coutada A</searchLink>; Department of Anatomical Pathology, Portuguese Oncology Institute, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Bento+MJ%22">Bento MJ</searchLink>; Epidemiology, Outcomes, Economics and Management in Oncology Group - Research Center (CI-IPOP), Porto Comprehensive Cancer Center (Porto.CCC), RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto, Porto, Portugal.; Department of Population Studies, Abel Salazar Institute of Biomedical Sciences, University of Porto, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Coimbra+N%22">Coimbra N</searchLink>; Department of Anatomical Pathology, Portuguese Oncology Institute, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Leal+C%22">Leal C</searchLink>; Department of Anatomical Pathology, Portuguese Oncology Institute, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Pereira+D%22">Pereira D</searchLink>; Department of Medical Oncology, Portuguese Oncology Institute, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Magalhães+Ferreira+A%22">Magalhães Ferreira A</searchLink>; Department of Medical Oncology, Portuguese Oncology Institute, Porto, Portugal.; Abel Salazar Institute of Biomedical Sciences, University of Porto, Porto, Portugal.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Sep 17; Vol. 15, pp. 1579602. <i>Date of Electronic Publication: </i>2025 Sep 17 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41040514
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2025.1579602
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1579602
    Titles:
      – TitleFull: The clinicopathological characteristics, oncologic outcomes and costs of "HER2-low" early breast cancer compared to HER2-zero and HER2-positive: a single-centre retrospective analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rodrigues PR
      – PersonEntity:
          Name:
            NameFull: Lopes-Conceição L
      – PersonEntity:
          Name:
            NameFull: Sousa V
      – PersonEntity:
          Name:
            NameFull: Coutada A
      – PersonEntity:
          Name:
            NameFull: Bento MJ
      – PersonEntity:
          Name:
            NameFull: Coimbra N
      – PersonEntity:
          Name:
            NameFull: Leal C
      – PersonEntity:
          Name:
            NameFull: Pereira D
      – PersonEntity:
          Name:
            NameFull: Magalhães Ferreira A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 09
              Text: 2025 Sep 17
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1